Rethinking Treatment in Rheumatoid Arthritis: Novel Approaches for Better Outcomes

Rethinking Treatment in Rheumatoid Arthritis: Novel Approaches for Better Outcomes is organized by Prime Education LLC.

Dates:
Release Date: November 15, 2019
Expiration Date: November 15, 2020

Accreditation:
• 1.25 CME/CE for Physicians (ACCME)
• 1.25 CME/CE for Physician Assistants (AAPA)
• 1.25 CME/CE for Physician Assistants (AAPA)
• 1.25 CME/CE for Nurse Practitioners (AANP)
• 1.25 CPE for Pharmacists (ACPE + NABP)
• 1.25 CNE for Nurses (ANCC)

Activity Overview:
An interprofessional panel of rheumatoid arthritis (RA) and managed care experts review the latest evidence coming from EULAR and other major rheumatology meetings. The discussion focuses on strategies to align managed care decision-making with current evidence in RA management.

Tune in for:
• Updates from EULAR and other major conferences
• The latest on therapy selection and patient-centered care in the modern era
• Case-based discussion on managed care strategies and decision-making for complex patients
• Expert Q&A: Answers to your most pressing questions

Learning Objectives:
• Assess new research on the pathogenesis of rheumatoid arthritis (RA) and the targeted effects of therapies that inhibit Janus kinase
• Evaluate current evidence on the efficacy and safety of new and emerging small-molecule therapies for moderately to severely active RA
• Apply comparative effectiveness evidence and guidelines in RA to managed care decision-making
• Incorporate medication therapy management strategies for promoting patient education and adherence to new and emerging targeted RA therapies

Additional details will be posted as soon as information is available.